Business Wire

St. Jude Medical Announces FDA Approval for Industry's Only MR-Conditional 5-Column Paddle Lead for the Management of Chronic Pain

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of MR-conditional labeling for ...
Nasdaq

St. Jude Medical's Penta Paddle Lead Labeling Gets FDA Nod - Analyst Blog

St. Jude Medical Inc.STJ recently announced that the company has received approval of MR-conditional labeling for the company's Penta 5-column paddle lead for spinal cord stimulation (SCS) therapy. St ...
Insurancenewsnet.com

New Data from University of Virginia Illuminate Findings in Neurology (Demographic Trends in Paddle Lead Spinal Cord Stimulator Placement: Private Insurance and Medicare ...

2020 FEB 21 (NewsRx) -- By a News Reporter-Staff News Editor at Health Policy and Law Daily-- Investigators publish new report on Health and Medicine - Neurology. According to news reporting ...
Pharmabiz

US FDA approves expanded MRI labelling for Abbott’s Eterna SCS system

Abbott announced that the US Food and Drug Administration (FDA) has approved expanded MRI labelling for its Eterna spinal cord stimulation (SCS) system to include new leads that are MR conditional, ...